| 社会责任影响下研发创新与医药供应链协调决策 |
| |
| 引用本文： | 陈晓春,张文松. 社会责任影响下研发创新与医药供应链协调决策[J]. 系统管理学报, 2021, 30(1): 159-169. DOI: 10.3969/j.issn.1005-2542.2021.01.015 |
| |
| 作者姓名： | 陈晓春 张文松 |
| |
| 作者单位： | 北京交通大学 经济管理学院，北京 100044 |
| |
| 基金项目： | 中央高校基本科研业务费专项资金资助项目(2019YJS060)。 |
| |
| 摘 要： | 基于医药制造商和医疗机构同时关注消费者剩余视角,把研发创新和医保支付作为影响消费者效用的内生因素,刻画不同决策模型中社会责任对均衡结果的影响.研究表明:无论是医药供应链整体,还是医药制造商单独关注社会责任,都有利于提升研发创新能力;在非合作决策下,医药制造商积极履行社会责任可有效控制药品批发和零售价格,增加利益相关者的...
|
| 关 键 词： | 社会责任 研发创新 医药供应链 组合契约 |
Research and Development Innovation and Pharmaceutical Supply Chain Coordination Under the Influence of Social Responsibility |
| |
| CHEN Xiaochun,ZHANG Wensong. Research and Development Innovation and Pharmaceutical Supply Chain Coordination Under the Influence of Social Responsibility[J]. Systems Engineering Theory·Methodology·Applications, 2021, 30(1): 159-169. DOI: 10.3969/j.issn.1005-2542.2021.01.015 |
| |
| Authors: | CHEN Xiaochun ZHANG Wensong |
| |
| Affiliation: | School of Economics and Management，Beijing Jiaotong University，Beijing 100044，China |
| |
| Abstract: | Based on the perspective that the pharmaceutical manufacturer and medical institution pay attention to consumer surplus at the same time,this paper,taking research and development innovation and medical insurance payment as endogenous factors that affect consumer utility,depicts the impact of social responsibility on equilibrium results in different decision making models.The research shows that whether it is the whole pharmaceutical supply chain or the pharmaceutical manufacturers’individual focus on social responsibility,it is beneficial to enhance the research and development innovation ability in the three kinds of decision-making models.In the non-cooperative decision-making model,enhancing the social responsibility of the pharmaceutical manufacturer can effectively control the wholesale and retail prices of drugs,increase the income of stakeholders and the surplus value of consumers,but it will weaken its own profitability.However,as the overall social responsibility of the supply chain increases,improving the level of social responsibility shared within the threshold is conducive to the value-added of the pharmaceutical manufacturer.The combination contract coordination strategy consisting of government subsidies,collaborative innovation,and collective procurement optimizes the pharmaceutical supply chain,which can effectively stimulate the power of innovation and increase overall social welfare. |
| |
| Keywords: | social responsibility research and development innovation pharmaceutical supply chain com bination contract |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《系统管理学报》浏览原始摘要信息 |
|
点击此处可从《系统管理学报》下载全文 |
|
